Hu Yanjie, Associate Chief Physician of the Department of Pulmonary and Critical Care Medicine. Dr. Hu’s clinical and research interests are the diagnosis and treatment of lung cancer, especially the the design and conduct of clinical trials of new chemotherapies and cellular immunotherapies in lung cancer. Dr. Hu  mainly focouses on the early diagnosis of lung cancer.

Lung cancer (Clinical trials and Chemotherapy)

Pulmonary embolism and DVT

Chronic airway diseases (COPD, Asthma, Bronchiectasis)

Respiratory infectious diseases

Lung cancer, especially  the design and conduct of clinical trials of new chemotherapies and cellular immunotherapies in lung cancer.

Secretary and youth member of the Tumor-targeted and Cellular Therapy Committee, Zhejiang Anti-cancer Association.

Secretary of Zhejiang Chronic Respiratory Disease Office

Fellowship of the Tobacco-ssociated Disease Group, Pulmonology Branch of Zhejiang Medical Association

Fellowship of the COPD Group, Zhejiang Medical Doctor Association